ABGEN statistics

info info

Citations per year

Number of citations per year for the bioinformatics software tool ABGEN
info

Tool usage distribution map

This map represents all the scientific publications referring to ABGEN per scientific context
info info

Associated diseases

info

Popular tool citations

chevron_left Antibody modeling chevron_right
Want to access the full stats & trends on this tool?

ABGEN specifications

Information


Unique identifier OMICS_15507
Name ABGEN
Alternative name AntiBody structure GENeration
Software type Package/Module
Interface Command line interface
Restrictions to use Academic or non-commercial use
Operating system Windows
Computer skills Advanced
Version 1.0
Stability Stable
Maintained Yes

Versioning


No version available

Publication for AntiBody structure GENeration

ABGEN citations

 (17)
library_books

How B Cell Receptor Repertoire Sequencing Can Be Enriched with Structural Antibody Data

2017
Front Immunol
PMCID: 5727015
PMID: 29276518
DOI: 10.3389/fimmu.2017.01753

[…] the geometry of the binding site, allowing for the third step, which is modeling of non-H3 CDRs. At this stage, either the canonical classes are used () or template-based modeling such as FREAD () or ABGEN (). In the final step, CDR-H3 is modeled using either homology or ab initio techniques (). The resultant antibody model is refined for feasibility of dihedral angles from Ramachandran distributi […]

library_books

A transcriptional complex composed of ER(α), GATA3, FOXA1 and ELL3 regulates IL 20 expression in breast cancer cells

2017
Oncotarget
PMCID: 5522103
PMID: 28514748
DOI: 10.18632/oncotarget.17459

[…] cted with siRNA using siGENOME (Ell3, M-014601-01-0005; ER(α), L-003401-00-0010; GATA3, L-003781-00-0010; and FOXA1,L-010319-00-0010), which was provided by Dharmacon (distributed by ThermoScientific/AbGen, Epsom, UK). Cells were transfected with either target siRNA or non-specific siRNA using Lipofectamine 2000 (Invitrogen) in OPTI-MEM (Invitrogen) according to the manufacturer's instructions. […]

library_books

Antibody H3 Structure Prediction

2017
Comput Struct Biotechnol J
PMCID: 5312500
PMID: 28228926
DOI: 10.1016/j.csbj.2017.01.010

[…] el correctly, since it is thought to be mainly responsible for the antigen-binding properties of an antibody . While some algorithms exist that do not treat it any differently to the other CDRs (e.g. ABGEN ), this is not usual and a special approach is normally implemented, using a knowledge-based or ab initio approach, or some combination of the two. Some algorithms have tried to use the presence […]

library_books

Low glucose dependent decrease of apoptosis and induction of autophagy in breast cancer MCF 7 cells

2016
PMCID: 4887537
PMID: 27160935
DOI: 10.1007/s11010-016-2711-4

[…] Boston, USA), monoclonal (mouse) anti-human mTOR antibody (Merck-Millipore, USA), alkaline phosphatase-labeled anti-mouse immunoglobulin G by Rockland (PA, USA), polyclonal (rabbit) anti-human LC3 by Abgen, donkey anti-rabbit IgG conjugated with Alexa Fluor 488 by Molecular Probes (USA). […]

library_books

Expression Atlas of the Deubiquitinating Enzymes in the Adult Mouse Retina, Their Evolutionary Diversification and Phenotypic Roles

2016
PLoS One
PMCID: 4774998
PMID: 26934049
DOI: 10.1371/journal.pone.0150364

[…] Abcam ab19879), 1:100 Rabbit anti-USP13 (Abcam ab109264), 1:50 Rabbit anti-USP16 (Abcam ab135509), 1:100 Rabbit anti-USP22 (Abcam ab4812), 1:300 Rabbit anti-USP25 (in house), 1:250 Rabbit anti-USP28 (ABGEN AP2152b).1:500 for Mouse anti-Rhodopsin (Abcam, Cambridge, UK). Antibodies against AMSH (Biorbyt orb101007), JAB1 (Abcam ab12323), OTUB1 (Abcam ab76648), OTUD1 (Abcam ab122481), POH1 (Abcam ab80 […]

library_books

Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signals

2015
Oncotarget
PMCID: 4884958
PMID: 26556868
DOI: 10.18632/oncotarget.5467

[…] of 20 nM. Human CCL2 (MCP-1) recombinant protein was purchased from Affymetrix eBioscience (Santa Clara, CA, USA) and was adjusted to a final concentration of 10 nM. MMP9 inhibitor was purchased from ABGen and was adjusted to a final concentration of 5 μg/ml. […]


Want to access the full list of citations?
ABGEN funding source(s)
This work was supported by research grant GM46535 from the National Institutes of Health.

ABGEN reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review ABGEN